The BSc Pharmacology & Innovative Therapeutics degree programme led by Dr Sadani Cooray at the William Harvey Research Institute at Barts and the London School of Medicine and Dentistry has topped the national leader board for student satisfaction for Pharmacology in the 2020 National Student Survey (NSS).
The programme received 100% overall satisfaction ratings from final year students in the annual survey.
The BSc Pharmacology & Innovative Therapeutics degree at QMUL is offered either as a three-year undergraduate degree programme or as a 4-year degree programme with a year abroad. From 2020 we are also introducing the 4-year BSc Pharmacology & Innovative Therapeutics degree with a year in industry.
The degree programme was designed to meet the skills gap identified by the pharmaceutical and biotechnology industries. Students are given a strong foundation in biomedical science and molecular and clinical pharmacology whilst gaining an understanding of the drug development cycle, from initial idea to the patient’s bedside, through studying drug regulation, safety, bioethics, clinical trials, risk/benefit assessments and personalised medicine. The programme also explores the practical aspects of managing a pharmacology business, including research and development costs, pricing, marketing and licensing.
We are thrilled that our BSc Pharmacology students have recognised the high-quality teaching and support offered on our course. This outstanding result is a testament to the dedication, commitment and hard work of the entire team of academics and administrative staff involved in delivering the course. We would also like to thank our students for their remarkable dedication, resilience and hard work during the current COVID-19 pandemic.